Flow cytometry sample characteristics
ID . | Diagnosis . | FAB . | Karyotype . | WBC (x109/L) . |
---|---|---|---|---|
Patient no. 1 | De novo | M4 | 47,XX,+8[20] | 9.6 |
Patient no. 2 | De novo | M2 | 46,XX,T(8;21)(Q22;Q22)[6]/46,IDEM,DEL(7)(Q21Q36)[13]/46,XX[1] | 1.9 |
Patient no. 3 | sAML (after MDS) | M1 | Complex monosomal | 15.1 |
Patient no. 4 | De novo Relapse | M1 | 46,XX[20] | 176.5 |
Patient no. 5 | De novo | M2 | 47,XX,+11[4]/46,XX[16] | 2.3 |
Patient no. 6 | De novo | M1 | 46,XX[20] | 86.3 |
Patient no. 7 | De novo | M4 | 45,X,-Y,T(8;21)(Q22;Q22)[20] | 44.9 |
Patient no. 8 | De novo | M0 | 47,XY,+13[32]/46,XY[4] | 1.4 |
Patient no. 9 | sAML (after MDS) | M2 | 46,XY,DEL(5)(31Q35)[15]/47,IDEM,+14[3]/46,XY[7] | ND |
Patient no. 10 | De novo | M1 | 46,XX[20] | 8.7 |
Patient no. 11 | De novo | M2 | 46,XY[20] | 1.5 |
Patient no. 12 | De novo | M2 | Complex monosomal | 17.4 |
Patient no. 13 | De novo | M4 | 46,XY[20] | 7.3 |
Patient no. 14 | De novo | M4 | Complex monosomal | 11.2 |
Patient no. 15 | De novo | M2 | 46,XX,T(8;21)(Q22;Q22),T(11;17)(Q14;Q11-12)[20] | 4.4 |
Patient no. 16 | De novo | M2 | 47,XX,+8[4]/46,XX[20] | 2.9 |
Patient no. 17 | sAML (after MPN) | M0 | 46,XX,DEL(20)(Q11Q13)[2]/46,IDEM,DEL(7)(Q22Q32)[15]/46,XX[3] | 23.8 |
Patient no. 18 | De novo | NK | Complex monosomal | 11.4 |
Patient no. 19 | sAML (after MDS) | M1 | 46,XY[20] | 59 |
Patient no. 20 | De novo | NK | 47,XY,+8[21]/46,XY[1] | 1.3 |
Patient no. 21 | De novo | M1 | 46,XY[20] | 8.1 |
Patient no. 22 | De novo | M0 | NK | 1 |
Patient no. 23 | De novo | CMML | 46,XY[20] | 47.1 |
Patient no. 24 | De novo | M1 | 46,XX,DEL(7)(Q22Q36)[20] | 8.6 |
Patient no. 25 | De novo | M4 | Complex monosomal | 10 |
Patient no. 26 | De novo | M5 | 46,XY,ADD(17)(P1?3)[14]/46,XY[8] | 35 |
Patient no. 27 | De novo | NK | 46,XY[20] | 5.5 |
Patient no. 28 | De novo | NK | 46,XX[20] | 0.5 |
Patient no. 29 | De novo | M1 | Complex | 2.4 |
Patient no. 30 | De novo | M1 | 47,XX,+10[37]/46,IDEM,DEL(9)(Q12Q32)[3] | 136.9 |
Patient no. 31 | De novo | M4 | 46,XY[20] | 18.8 |
Patient no. 32 | De novo | M0 | 46,XY[40] | 185 |
Patient no. 33 | De novo | M6 | 46,XY,INV(3)(Q21Q26)[20] | 17.6 |
Patient no. 34 | De novo | M5 | Complex | 80.2 |
Patient no. 35 | De novo | M1 | 47,XX,+21[10]/46,XX[11] | 6.7 |
Patient no. 36 | De novo | M0 | 46,XY,?T(3;7;5)(P24;Q36;Q14)[20] | 66 |
Patient no. 37 | De novo | M0 | 46,XX[30] | 2 |
Patient no. 38 | De novo | M4 | 46,XY,INV(16)(P13Q22)[20] | 29.7 |
Patient no. 39 | sAML (after MDS) | M2 | 46,XY[20] | 5.6 |
Patient no. 40 | De novo | M2 | 46,XX[20] | 3.2 |
Patient no. 41 | De novo | M1 | Complex monosomal | 1 |
Patient no. 42 | De novo | M0 | 45,XX,-7,DER(21)T(7;21)(P11;P11)[20] | 2.8 |
Patient no. 43 | De novo | M1 | 46,XX[20] | 51.6 |
Patient no. 44 | De novo | M4 | Complex monosomal | 23.4 |
Patient no. 45 | De novo | M0 | Complex monosomal | 2.5 |
Patient no. 46 | De novo | M5 | 46,XY,T(9;11)(P21-22;Q23)[20] | 169.9 |
Patient no. 47 | sAML (after MPN) | M0 | 46,XY,DEL(7)(Q22Q36)[21]/46,IDEM,I(21)(Q10)[2] | 5.2 |
Patient no. 48 | De novo | M5 | 46,XY,T(6;9)(P22;Q34)[20] | 41.8 |
Patient no. 49 | De novo | M1 | 46,XX[20] | 21.8 |
Patient no. 50 | De novo | M5 | 46,XX,T(11;17)(Q23;Q12-21)[2]/47,IDEM,?DEL(11)(Q23 OR Q22Q24-)+21[20] | 54.1 |
Patient no. 51 | De novo | M2 | 46,XY[20] | 3.32 |
Patient no. 52 | De novo | M4 | 46,XX[20] | 19.1 |
Patient no. 53 | De novo | M2 | 46,XX[20] | 3.9 |
Patient no. 54 | De novo | M2 | 46,XY[20] | 48.9 |
Patient no. 55 | De novo | M2 | 46,XX[20] | 6.9 |
Patient no. 56 | De novo | NK | Complex monosomal | 17.5 |
Patient no. 57 | De novo | M5 | 47,XY,+21[21]/46,XY[1] | 29 |
Patient no. 58 | De novo | M2 | 45,XY,-7[3]/46,XY[17] | 146 |
Patient no. 59 | De novo | M4 | Complex monosomal | 2.5 |
Patient no. 60 | Patient no. 14 relapse | |||
Patient no. 61 | Patient no. 31 relapse | |||
Patient no. 62 | Patient no. 40 relapse |
ID . | Diagnosis . | FAB . | Karyotype . | WBC (x109/L) . |
---|---|---|---|---|
Patient no. 1 | De novo | M4 | 47,XX,+8[20] | 9.6 |
Patient no. 2 | De novo | M2 | 46,XX,T(8;21)(Q22;Q22)[6]/46,IDEM,DEL(7)(Q21Q36)[13]/46,XX[1] | 1.9 |
Patient no. 3 | sAML (after MDS) | M1 | Complex monosomal | 15.1 |
Patient no. 4 | De novo Relapse | M1 | 46,XX[20] | 176.5 |
Patient no. 5 | De novo | M2 | 47,XX,+11[4]/46,XX[16] | 2.3 |
Patient no. 6 | De novo | M1 | 46,XX[20] | 86.3 |
Patient no. 7 | De novo | M4 | 45,X,-Y,T(8;21)(Q22;Q22)[20] | 44.9 |
Patient no. 8 | De novo | M0 | 47,XY,+13[32]/46,XY[4] | 1.4 |
Patient no. 9 | sAML (after MDS) | M2 | 46,XY,DEL(5)(31Q35)[15]/47,IDEM,+14[3]/46,XY[7] | ND |
Patient no. 10 | De novo | M1 | 46,XX[20] | 8.7 |
Patient no. 11 | De novo | M2 | 46,XY[20] | 1.5 |
Patient no. 12 | De novo | M2 | Complex monosomal | 17.4 |
Patient no. 13 | De novo | M4 | 46,XY[20] | 7.3 |
Patient no. 14 | De novo | M4 | Complex monosomal | 11.2 |
Patient no. 15 | De novo | M2 | 46,XX,T(8;21)(Q22;Q22),T(11;17)(Q14;Q11-12)[20] | 4.4 |
Patient no. 16 | De novo | M2 | 47,XX,+8[4]/46,XX[20] | 2.9 |
Patient no. 17 | sAML (after MPN) | M0 | 46,XX,DEL(20)(Q11Q13)[2]/46,IDEM,DEL(7)(Q22Q32)[15]/46,XX[3] | 23.8 |
Patient no. 18 | De novo | NK | Complex monosomal | 11.4 |
Patient no. 19 | sAML (after MDS) | M1 | 46,XY[20] | 59 |
Patient no. 20 | De novo | NK | 47,XY,+8[21]/46,XY[1] | 1.3 |
Patient no. 21 | De novo | M1 | 46,XY[20] | 8.1 |
Patient no. 22 | De novo | M0 | NK | 1 |
Patient no. 23 | De novo | CMML | 46,XY[20] | 47.1 |
Patient no. 24 | De novo | M1 | 46,XX,DEL(7)(Q22Q36)[20] | 8.6 |
Patient no. 25 | De novo | M4 | Complex monosomal | 10 |
Patient no. 26 | De novo | M5 | 46,XY,ADD(17)(P1?3)[14]/46,XY[8] | 35 |
Patient no. 27 | De novo | NK | 46,XY[20] | 5.5 |
Patient no. 28 | De novo | NK | 46,XX[20] | 0.5 |
Patient no. 29 | De novo | M1 | Complex | 2.4 |
Patient no. 30 | De novo | M1 | 47,XX,+10[37]/46,IDEM,DEL(9)(Q12Q32)[3] | 136.9 |
Patient no. 31 | De novo | M4 | 46,XY[20] | 18.8 |
Patient no. 32 | De novo | M0 | 46,XY[40] | 185 |
Patient no. 33 | De novo | M6 | 46,XY,INV(3)(Q21Q26)[20] | 17.6 |
Patient no. 34 | De novo | M5 | Complex | 80.2 |
Patient no. 35 | De novo | M1 | 47,XX,+21[10]/46,XX[11] | 6.7 |
Patient no. 36 | De novo | M0 | 46,XY,?T(3;7;5)(P24;Q36;Q14)[20] | 66 |
Patient no. 37 | De novo | M0 | 46,XX[30] | 2 |
Patient no. 38 | De novo | M4 | 46,XY,INV(16)(P13Q22)[20] | 29.7 |
Patient no. 39 | sAML (after MDS) | M2 | 46,XY[20] | 5.6 |
Patient no. 40 | De novo | M2 | 46,XX[20] | 3.2 |
Patient no. 41 | De novo | M1 | Complex monosomal | 1 |
Patient no. 42 | De novo | M0 | 45,XX,-7,DER(21)T(7;21)(P11;P11)[20] | 2.8 |
Patient no. 43 | De novo | M1 | 46,XX[20] | 51.6 |
Patient no. 44 | De novo | M4 | Complex monosomal | 23.4 |
Patient no. 45 | De novo | M0 | Complex monosomal | 2.5 |
Patient no. 46 | De novo | M5 | 46,XY,T(9;11)(P21-22;Q23)[20] | 169.9 |
Patient no. 47 | sAML (after MPN) | M0 | 46,XY,DEL(7)(Q22Q36)[21]/46,IDEM,I(21)(Q10)[2] | 5.2 |
Patient no. 48 | De novo | M5 | 46,XY,T(6;9)(P22;Q34)[20] | 41.8 |
Patient no. 49 | De novo | M1 | 46,XX[20] | 21.8 |
Patient no. 50 | De novo | M5 | 46,XX,T(11;17)(Q23;Q12-21)[2]/47,IDEM,?DEL(11)(Q23 OR Q22Q24-)+21[20] | 54.1 |
Patient no. 51 | De novo | M2 | 46,XY[20] | 3.32 |
Patient no. 52 | De novo | M4 | 46,XX[20] | 19.1 |
Patient no. 53 | De novo | M2 | 46,XX[20] | 3.9 |
Patient no. 54 | De novo | M2 | 46,XY[20] | 48.9 |
Patient no. 55 | De novo | M2 | 46,XX[20] | 6.9 |
Patient no. 56 | De novo | NK | Complex monosomal | 17.5 |
Patient no. 57 | De novo | M5 | 47,XY,+21[21]/46,XY[1] | 29 |
Patient no. 58 | De novo | M2 | 45,XY,-7[3]/46,XY[17] | 146 |
Patient no. 59 | De novo | M4 | Complex monosomal | 2.5 |
Patient no. 60 | Patient no. 14 relapse | |||
Patient no. 61 | Patient no. 31 relapse | |||
Patient no. 62 | Patient no. 40 relapse |
FAB, French-American-British classification; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm; NK, Not Known; ND, Not Determined; sAML, secondary AML.